BG Medicine Inc (BGMD)
0.00
USD |
OTCM |
Apr 25, 16:00
BG Medicine Net Income (Quarterly): -0.902M for Dec. 31, 2015
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2015 | -0.902M |
September 30, 2015 | -1.023M |
June 30, 2015 | -2.029M |
March 31, 2015 | -1.348M |
December 31, 2014 | -1.32M |
September 30, 2014 | -2.397M |
June 30, 2014 | -2.169M |
March 31, 2014 | -2.179M |
December 31, 2013 | -1.935M |
September 30, 2013 | -3.665M |
June 30, 2013 | -4.837M |
March 31, 2013 | -5.412M |
December 31, 2012 | -2.899M |
September 30, 2012 | -6.814M |
June 30, 2012 | -6.393M |
March 31, 2012 | -7.663M |
December 31, 2011 | -4.734M |
Date | Value |
---|---|
September 30, 2011 | -4.881M |
June 30, 2011 | -4.836M |
March 31, 2011 | -3.131M |
December 31, 2010 | -3.323M |
September 30, 2010 | -4.487M |
June 30, 2010 | -3.742M |
March 31, 2010 | -5.61M |
December 31, 2009 | -4.237M |
September 30, 2009 | -4.397M |
September 30, 2007 | -2.179M |
June 30, 2007 | -2.03M |
March 31, 2007 | -1.537M |
December 31, 2006 | -0.028M |
September 30, 2006 | -1.267M |
June 30, 2006 | -1.297M |
March 31, 2006 | -2.15M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
Delcath Systems Inc | -11.14M |
Star Equity Holdings Inc | 1.728M |
Exact Sciences Corp | -49.77M |
CytoSorbents Corp | -5.835M |
Progyny Inc | 13.47M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 0.29M |
Total Expenses (Quarterly) | 1.192M |
EPS Diluted (Quarterly) | -0.06 |